1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRCA1 immunohistochemistry in high-grade serous ovarian cancers (HGS-OC) characterized for BRCA1 germ-line mutations
    Meeting Abstract

    Hyman, D. M.; Garg, K.; Grisham, R. N.; Bhatia, J.; Arnold, A. G.; Aghajanian, C.; Kauff, N. D.; Levine, D. A.; Soslow, R. A.; Spriggs, D. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Factors associated with life expectancy (LE) < 3 months (mo) among older adults receiving palliative chemotherapy (chemo)
    Meeting Abstract

    Hurria, A.; Hardt, M.; Tew, W. P.; Mohile, S. G.; Owusu, C.; Gross, C. P.; Gajra, A.; Lichtman, S. M.; Katheria, V.; Ramani, R.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Progression-free survival for subsequent relapses in patients with peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Horwitz, S. M.; Delarue, R.; Lunning, M. A.; Vose, J.; Coiffier, B.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Defining the genetic basis of everolimus sensitivity in metastatic bladder cancer (MBC) by whole-genome sequencing (WGS)
    Meeting Abstract

    Iyer, G.; Milowsky, M. I.; Al-Ahmadie, H.; Hanrahan, A.; Janakiraman, M.; Heguy, A.; Viale, A.; Socci, N. D.; Sander, C.; Bochner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Effect of IL-22 on intestinal stem cells, GVHD-related tissue damage, and GVL
    Meeting Abstract

    Hanash, A. M.; Van Den Brink, M. R. M.; Hua, G.; Kolesnick, R.; Blazar, B. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A national survey of general internists' preferences and knowledge gaps regarding the care of childhood cancer survivors
    Meeting Abstract

    Henderson, T. O.; Nathan, P. C.; Rasinski, K.; Suh, E.; Kigin, M.; Wroblewski, K.; Ford, J.; Tonorezos, E. S.; Oeffinger, K. C.; Daugherty, C.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the MEK inhibitor selumetinib
    Meeting Abstract

    Ho, A. L.; Leboeuf, R.; Grewal, R. K.; Sherman, E. J.; Deandreis, D.; Pentlow, K. S.; Tuttle, R. M.; Fury, M. G.; Ricarte-Filho, J. C. M.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Hypersensitivity skin reactions in melanoma patients treated with vemurafenib after ipilimumab therapy
    Meeting Abstract

    Harding, J. J.; Lacouture, M. E.; Pulitzer, M.; Callahan, M.; Postow, M. A.; Carvajal, R. D.; Wolchok, J. D.; Chapman, P. B.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma
    Meeting Abstract

    Herman, J. M.; Chang, D. T.; Goodman, K. A.; Wild, A. T.; Laheru, D.; Zheng, L.; Diaz, L. A.; Le, D. T.; Raman, S. P.; Leal, J. P.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save